Viewing Study NCT06781905

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:20 AM
Ignite Modification Date: 2026-02-25 @ 6:32 PM
Study NCT ID: NCT06781905
Status: RECRUITING
Last Update Posted: 2025-12-16
First Post: 2025-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Description of Neurocognitive and Psychiatric Disorders Associated With Targeted Therapies Used in the Treatment of Lung Cancers With ALK/ROS1 Fusion and Their Impact on Patients' Quality of Life: Construction of an Experimental Patient-researcher Collaborative Care and Research Pathway
Sponsor: Hospices Civils de Lyon
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Lung Cancer View
None Metastatic Lung Cancer With ALK/ROS1 Fusion View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neurocognitive disorders View
None Targeted therapies View
None Quality of life View
None Lung cancer View
None Collaborative research View
None Care pathway View